Melanoma Stage 1 BAD pdf


What are the aims of this leaflet?
This leaflet provides you with information about stage 1 melanoma. In
particular, it tells you what a stage 1 melanoma is, what will be the
investigations/treatments and where to find out more information. It has been
prepared in response to some of the questions people with melanoma often

What is melanoma?

Melanoma is a type of skin cancer, which arises from the pigment cells
(melanocytes) in the skin. In a melanoma skin cancer the melanocytes
become malignant and multiply excessively. One of the most important
causes of melanoma is exposure to too much ultraviolet light in sunlight. The
use of artificial sources of ultraviolet light, such as sunbeds, also increases
the risk of getting a melanoma.
Melanocytes make a brown/black pigment (known as melanin), and often the
first sign of a melanoma developing is a previous mole changing in colour or a
new brown/black lesion developing. Most frequently there is darkening in
colour but occasionally there is loss of pigmentation with pale areas or red
areas developing. This melanoma on the skin is known as the primary
Melanoma is considered to be the most serious type of skin cancer because it
is more likely to spread (metastasise) from the skin to other parts of the body
than other types of skin cancer. If melanoma has spread to other parts of the
body, those deposits are known as secondary melanoma

Diagnosis and initial treatment

Although a diagnosis of melanoma can be serious, most melanomas are
caught at an early stage and so do not cause any further problem. If lesions
are not caught at the early stages then there is a higher risk of the melanoma
spreading, which can reduce life expectancy.
The initial treatment for a suspected melanoma is to cut out (excise) all of the
melanoma cells. When the lesion is first removed, we do not know for sure if it
is a melanoma or not, and if it is a melanoma how thick it is, so the excision is
usually done with narrow margins (the area of normal skin around the suspected
The specimen that is cut out from the skin is sent to a
laboratory, so that a pathologist can examine it under the microscope.
Pathologists look to see if what has been removed is a melanoma and how
thick it is. This is the only way a diagnosis of melanoma can be confirmed.

What is stage 1 melanoma?

Doctors use a staging system for melanoma to indicate both the outcome and
the best treatment. The system used in the UK stages melanoma from 1 to 4.
Stage 1 is the earliest melanoma and stage 4 is the most advanced. The
staging system takes into account if there has been any spread of melanoma
from the skin to other parts of the body. Stage 1 and 2 melanomas are
present in the skin only and have not spread elsewhere in the body. Stage 3
and 4 melanomas are those that have spread to other parts of the body.
The pathologist will look under the microscope to measure certain features of the
melanoma. These include the thickness of the melanoma (called Breslow
thickness, after Dr Breslow who described it), which measures how far the
melanoma cells have grown (or invaded) down into the layers of skin. The pathologist
will also note other special features under the microscope. These
findings are then summarised in a pathology (histology) report. This is used as part of
the staging process and according to this system you have been
diagnosed with stage 1 melanoma. Stage 1 is considered a thin melanoma.
You can discuss this in more detail with the medical team looking after you
if you would like to know more.

What happens next?

A team of experts (including dermatologists, surgeons, pathologists, a doctor specialising
in cancer treatment and specialist nurses) will meet to discuss the best treatment option(s)
for you. A member of the team will explain those options and you may also meet a
melanoma/skin cancer clinical nurse specialist (CNS) who may be the point of contact for
you and advise you accordingly.

How is stage 1 melanoma treated?

Removing the melanoma from the skin by surgery offers the best chance of a complete cure,
and this treatment alone is usually successful in stage 1 melanoma. Most patients do NOT need
either radiotherapy or chemotherapy.
After the melanoma was initially removed for histological diagnosis you will usually be offered
a second surgical procedure to remove more skin from around and beneath the melanoma scar.
This second procedure typically removes a further 1cm margin of skin around the first scar site.
It is called a Wide Local Excision (WLE) and is usually carried out under local anaesthetic
(via an injection to numb the skin). Your doctor will discuss with you how much skin will need
to be removed as the recommended margin depends on the thickness of the melanoma.
The purpose of this further surgery is to try and make sure that no cancer cells are left behind
in the nearby skin.

What scar(s) can I expect following a wide local excision?

The type of scar(s) will depend on location and the type of surgical technique
required. The WLE might result in a scar similar in shape but bigger in size
than the one that was left by cutting out the original melanoma. Some scars can be more
complex in shape because a “flap” or skin graft was required.
Further information on flaps and grafts can be found via the website links
given at the end of the leaflet.

What is the risk of stage 1 melanoma recurring?

A diagnosis of stage 1 melanoma means it has been caught early and most
patients don’t have further recurrence of their melanoma once treated. If you want to
know more precisely the chances of your melanoma recurring, talk to your dermatologist
and/or your CNS.

After treatment, why am I followed up?

Patients are routinely followed up in the out-patient clinics after the completion of the
WLE for three reasons:

1) To check that the melanoma has not come back or spread.

2) To detect new melanomas or other skin cancers.

3) To provide support, information and education.

How often and for how long will I be followed up?

The follow-up plan should be agreed between you and your dermatologist and/or the
surgeon who did the WLE. You will most likely see your doctor every 3 months, for
between 1 and 3 years. It is not unusual for your follow up to be shared between the
different doctors, and/or a CNS, involved in your care.

How will a recurrence of the melanoma or a new melanoma be detected?

Your doctor will want to examine the area of your melanoma scar and also check your
lymph nodes (glands). They will also ask to examine your entire skin to make sure there
are no signs of any new melanomas. Photographs might be taken to help compare the
way your moles look now with how they looked before and will be kept in your notes if
you agree. If a new or recurrent melanoma is suspected then, as before, it will most likely
be removed surgically.

What makes somebody more at risk of developing a new melanoma?

One of the biggest risk factors is a strong family history of melanoma (3 or
more family members affected). The following are also risk factors:

  • Having fair skin that burns easily in the sun, freckles and/or red hair.
  • A history of severe sunburn, especially sunburn that caused blisters,
    occurring in childhood.
  • A “weaker” family history of melanoma, i.e. only 1 or 2 other family
    members affected.
  • A large number of moles, and moles which are large and irregular in colour and
    shape (‘atypical” moles).
  • Having a very large dark birthmark (a giant congenital mole)
  • Having already had a melanoma.
  • A weakened immune system (for example, because of treatment with
    immunosuppressive drugs).

Self care (What can I do?)

Normally, your CNS will discuss the following with you after treatment:
You can examine your skin
Most patients do not develop further melanomas; however, some do and they may
also develop other forms of skin cancer. The best way to detect skin cancer is to check
all your skin every month (please see Patient Information Leaflet on early detection).
Essentially, you are looking for changes in the size, shape or colour of any moles, a new
mole, or a mole that looks different to the others. There are patient information
web-packages, which outline how to look after your moles
(please see the web links at the end of this leaflet).

Reduce the risk of further melanomas

The best way you can reduce risk is to not let your skin burn in the sun. You do not have
to hide from sunny days, but you do need to be careful to avoid turning pink and this
applies also to any children you have as they are likely to have a similar skin type to you.
Information on the best methods of sun protection can be found on the website links
provided at the end of this leaflet (see Patient Information Leaflet on prevention).

Top sun safety tips:

  • Protect your skin with clothing, and don’t forget to wear a hat that
    protects your face, neck and ears, and a pair of UV protective sunglasses.
  • Spend time in the shade between 11am and 3pm when it’s sunny. Step out of the
    sun before your skin has a chance to redden or burn.
  • When choosing a sunscreen look for a high protection SPF (SPF 30 or more) to
    protect against UVB, and the UVA circle logo and/or 4 or 5 UVA stars to protect
    against UVA. Apply plenty of sunscreen 15 to 30 minutes before going out in the
    sun, and reapply every two hours and straight after swimming and towel-drying.
  • Keep babies and young children out of direct sunlight.

The British Association of Dermatologists recommends that you tell your doctor about any
changes to a mole or patch of skin. If your GP is concerned about your skin, make sure you
see a Consultant Dermatologist – an expert in diagnosing skin cancer. Your doctor can refer
you for free through the NHS.
Sunscreens should not be used as an alternative to clothing and shade, rather they offer
additional protection. No sunscreen will provide 100% protection.
It may be worth taking Vitamin D supplement tablets (available from health food stores)
as strictly avoiding sunlight can reduce Vitamin D levels.

Vitamin D advice

The evidence relating to the health effects of serum Vitamin D levels,
sunlight exposure and Vitamin D intake remains inconclusive. Avoiding all sunlight exposure
if you suffer from light sensitivity, or to reduce the risk of melanoma and other skin cancers,
may be associated with Vitamin D deficiency.
Individuals avoiding all sun exposure should consider having their serum
Vitamin D measured. If levels are reduced or deficient they may wish to
consider taking supplementary vitamin D3, 10-25 micrograms per day, and
increasing their intake of foods high in Vitamin D such as oily fish, eggs, meat, fortified
margarines and cereals. Vitamin D3 supplements are widely available from health food shops.

Having had a melanoma may impact on future applications for life or health
insurance, particularly for the first five years after diagnosis. If you have
particular concerns about this, you should seek financial advice.

Where can I get more advice, support & information about melanoma?

When you have been diagnosed with melanoma you might experience a
range of emotions including worry, confusion or even feeling unable to cope. It will probably help
if you discuss and share your thoughts and feelings with someone close. This might be a family
member or friend. It could also be your doctor, CNS or another member of the team looking after you.

When you are diagnosed with melanoma, you will be given a lot of information. All this
information at once can be hard to take in. If you are not clear about anything during your
treatment, please don’t be afraid to ask.

Web links to detailed leaflets:

British Association of Dermatologists
Information on early detection and prevention of melanoma

Information on sun-safety

Information on Vitamin D

Cancer Research UK (CRUK)

Information on sun-safety

GenoMEL: The Melanoma Genetics Consortium
Information on looking after your moles and vitamin D

Macmillan Cancer Support

Information on flaps/grafts

National Cancer Action Team (NCAT)/ NHS Choices
Create your own personalised information

Information on Vitamin D

For details of source materials used please contact the Clinical Standards Unit

This leaflet aims to provide accurate information about the subject and
is a consensus of the views held by representatives of the British
Association of Dermatologists: its contents, however, may occasionally
differ from the advice given to you by your doctor. This leaflet has been assessed for readability
by the British Association of Dermatologists’ Patient Information Lay Review Panel

Download PDF version from the British Association of Dermatologists